Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis.

Kawashiri SY, Fujikawa K, Nishino A, Takatani A, Shimizu T, Umeda M, Fukui S, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Mizokami A, Maeda T, Kawakami A.

Int J Rheum Dis. 2019 Mar 18. doi: 10.1111/1756-185X.13543. [Epub ahead of print]

PMID:
30883001
2.

Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study.

Ichinose K, Kitamura M, Sato S, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Koga T, Kawashiri S, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Lupus. 2019 Feb 12:961203319829827. doi: 10.1177/0961203319829827. [Epub ahead of print]

PMID:
30755146
3.

Novel multiple heterozygous NUDT15 variants cause an azathioprine-induced severe leukopenia in a patient with systemic lupus erythematosus.

Otsuka M, Koga T, Sumiyoshi R, Furukawa K, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Clin Immunol. 2019 Mar;200:64-65. doi: 10.1016/j.clim.2019.02.004. Epub 2019 Feb 8. No abstract available.

PMID:
30742971
4.

Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed Due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab.

Aikawa E, Shimizu T, Koga T, Endo Y, Umeda M, Hori T, Irie J, Kuroda K, Eguchi M, Okamoto M, Tsuji S, Takatani A, Igawa T, Sumiyoshi R, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.2277-18. [Epub ahead of print]

5.

Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.

Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri S, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Lupus. 2019 Mar;28(3):295-303. doi: 10.1177/0961203319826690. Epub 2019 Jan 30.

PMID:
30700214
6.

Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis.

Fukui S, Kuwahara-Takaki A, Ono N, Sato S, Koga T, Kawashiri SY, Iwanaga N, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Migita K, Arinobu Y, Niiro H, Tada Y, Akashi K, Maeda T, Kawakami A.

Sci Rep. 2019 Jan 24;9(1):688. doi: 10.1038/s41598-018-36825-y.

7.

Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practice.

Umeda M, Koga T, Ichinose K, Takatani A, Igawa T, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Aramaki T, Ueki Y, Okada A, Fujikawa K, Matsuoka N, Kawakami A.

Immunol Med. 2018 Dec;41(4):181-186. doi: 10.1080/25785826.2018.1542942. Epub 2019 Jan 11.

PMID:
30632931
8.

Utility of power Doppler ultrasonography for detecting forefoot bursae in early rheumatoid arthritis: A case report.

Endo Y, Koga T, Eguchi M, Okamoto M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Medicine (Baltimore). 2018 Dec;97(51):e13295. doi: 10.1097/MD.0000000000013295.

9.

A Rare Case of Cryopyrin-associated Periodic Syndrome in an Elderly Woman with NLRP3 and MEFV Mutations.

Nakamichi S, Origuchi T, Fukui S, Yoda A, Matsubara H, Nagaura Y, Nishikomori R, Abe K, Migita K, Sakamoto N, Kawakami A, Ozono Y, Maeda T.

Intern Med. 2018 Dec 18. doi: 10.2169/internalmedicine.1401-18. [Epub ahead of print]

10.

Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.

Kawashiri SY, Origuchi T, Umeda M, Nishino A, Shimizu T, Fukui S, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Maeda T, Kawano M, Yamamoto M, Izumi Y, Kawakami A.

Arthritis Res Ther. 2018 Dec 14;20(1):277. doi: 10.1186/s13075-018-1777-7.

11.

Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29.

PMID:
30498034
12.

Calcium/calmodulin-dependent protein kinase 4 promotes GLUT1-dependent glycolysis in systemic lupus erythematosus.

Koga T, Sato T, Furukawa K, Morimoto S, Endo Y, Umeda M, Sumiyoshi R, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Kawakami A.

Arthritis Rheumatol. 2018 Nov 21. doi: 10.1002/art.40785. [Epub ahead of print]

PMID:
30462889
13.

Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Agematsu K, Yachie A, Masumoto J, Migita K, Kawakami A.

Arthritis Res Ther. 2018 Nov 20;20(1):257. doi: 10.1186/s13075-018-1738-1.

14.

Paraneoplastic Syndrome Presenting with Polymyalgia Rheumatica-like Accumulations on 18F-fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.

Umetsu A, Shimizu T, Iwamoto N, Hashiguchi K, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Igawa T, Sumiyoshi R, Koga T, Kawashiri SY, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2019 Mar 15;58(6):861-864. doi: 10.2169/internalmedicine.1847-18. Epub 2018 Nov 19.

15.

Antineutrophilic cytoplasmic antibody-associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does not.

Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Tamai M, Ichinose K, Nakamura H, Origuchi T, Sato S, Kawakami A.

Int J Rheum Dis. 2018 Nov 5. doi: 10.1111/1756-185X.13422. [Epub ahead of print]

PMID:
30398012
16.

Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis.

Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri SY, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Clin Immunol. 2018 Dec;197:161-168. doi: 10.1016/j.clim.2018.10.002. Epub 2018 Oct 5.

PMID:
30296591
17.

Evaluation of circulating invariant T cells before and after IL-17 inhibitor treatment in a patient with psoriatic arthritis.

Koga T, Matoba M, Sato T, Koike Y, Endo Y, Sumiyoshi R, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Clin Immunol. 2018 Dec;197:107-109. doi: 10.1016/j.clim.2018.09.011. Epub 2018 Sep 21. No abstract available.

PMID:
30248399
18.

Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.

Hara K, Endo Y, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Migita K, Kawakami A, Koga T.

Medicine (Baltimore). 2018 Sep;97(38):e12305. doi: 10.1097/MD.0000000000012305.

19.

Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.

Iwamoto N, Okamoto M, Tsuji S, Endo Y, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Igawa T, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Nakamura H, Origuchi T, Eguchi K, Ueki Y, Kawakami A.

J Bone Miner Metab. 2018 Sep 5. doi: 10.1007/s00774-018-0955-7. [Epub ahead of print]

PMID:
30187273
20.

Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010.

Ichinose K, Shimizu T, Umeda M, Fukui S, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Sato S, Origuchi T, Kawakami A.

J Immunol Res. 2018 Aug 14;2018:6259010. doi: 10.1155/2018/6259010. eCollection 2018.

21.

Osteogenic differentiation of fibroblast-like synovial cells in rheumatoid arthritis is induced by microRNA-218 through a ROBO/Slit pathway.

Iwamoto N, Fukui S, Takatani A, Shimizu T, Umeda M, Nishino A, Igawa T, Koga T, Kawashiri SY, Ichinose K, Tmai M, Nakamura H, Origuchi T, Chiba K, Osaki M, Jüngel A, Gay S, Kawakami A.

Arthritis Res Ther. 2018 Aug 29;20(1):189. doi: 10.1186/s13075-018-1703-z.

22.

Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.

Shimizu T, Iwamoto N, Okamoto M, Endo Y, Tsuji S, Takatani A, Igawa T, Umeda M, Fukui S, Sumiyoshi R, Kitamura M, Koga T, Kawashiri SY, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Intern Med. 2019 Feb 1;58(3):441-445. doi: 10.2169/internalmedicine.1441-18. Epub 2018 Aug 24.

23.

Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis.

Fujita Y, Fukui S, Suzuki T, Ishida M, Endo Y, Tsuji S, Takatani A, Igawa T, Shimizu T, Umeda M, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Abe K, Kawakami A.

Intern Med. 2018 Dec 1;57(23):3473-3478. doi: 10.2169/internalmedicine.1121-18. Epub 2018 Jul 6.

24.

Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Hosono Y, Mimori T, Kawakami A.

Medicine (Baltimore). 2018 Jun;97(26):e11024. doi: 10.1097/MD.0000000000011024.

25.

Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.

Koga T, Umeda M, Endo Y, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Murakami N, Kitajima M, Kawakami A.

Int J Rheum Dis. 2018 Jun;21(6):1287-1292. doi: 10.1111/1756-185X.13318.

PMID:
29879312
26.

Serum complement factor C5a in IgG4-related disease.

Fukui S, Fujita Y, Origuchi T, Maeda T, Kawakami A.

Ann Rheum Dis. 2018 Jun 6. pii: annrheumdis-2018-213705. doi: 10.1136/annrheumdis-2018-213705. [Epub ahead of print] No abstract available.

PMID:
29875095
27.

Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive Therapy.

Fujita Y, Fukui S, Ishida M, Endo Y, Tsuji S, Takatani A, Igawa T, Shimizu T, Umeda M, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2018 Oct 15;57(20):3025-3028. doi: 10.2169/internalmedicine.0934-18. Epub 2018 May 18.

28.

The efficacy of adjunct tacrolimus treatment in pregnancy outcomes in patients with systemic lupus erythematosus.

Ichinose K, Sato S, Kitajima Y, Horai Y, Fujikawa K, Umeda M, Fukui S, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yasuhi I, Masuzaki H, Kawakami A.

Lupus. 2018 Jul;27(8):1312-1320. doi: 10.1177/0961203318770536. Epub 2018 Apr 17.

PMID:
29665758
29.

Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.

Kawashiri SY, Nishino A, Igawa T, Takatani A, Shimizu T, Umeda M, Fukui S, Okada A, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakashima M, Mizokami A, Matsuoka N, Migita K, Ogawa F, Ikeda S, Maemura K, Nakamura H, Origuchi T, Maeda T, Kawakami A.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):102-108. Epub 2018 Apr 12.

30.

Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.

Endo Y, Koga T, Suzuki T, Hara K, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Kawakami A.

Medicine (Baltimore). 2018 Apr;97(15):e0436. doi: 10.1097/MD.0000000000010436.

31.

Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2018 Aug 1;57(15):2247-2250. doi: 10.2169/internalmedicine.0335-17. Epub 2018 Mar 9.

32.

Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in Japan.

Nishino A, Kawashiri SY, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Hamada H, Tsuru T, Nagano S, Arinobu Y, Hidaka T, Kawakami A.

Arthritis Care Res (Hoboken). 2018 Dec;70(12):1719-1726. doi: 10.1002/acr.23551.

PMID:
29481732
33.

Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.

Suzuki T, Fukui S, Umekita K, Miyamoto J, Umeda M, Nishino A, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Fujikawa K, Aramaki T, Mizokami A, Matsuoka N, Ueki Y, Eguchi K, Sato S, Hidaka T, Origuchi T, Okayama A, Kawakami A, Nakamura H.

Arthritis Rheumatol. 2018 Jul;70(7):1014-1021. doi: 10.1002/art.40461. Epub 2018 May 25.

PMID:
29471588
34.

M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to Osteoclastogenesis.

Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M, Nishino A, Horai Y, Hirai Y, Koga T, Kawashiri SY, Tamai M, Ichinose K, Nakamura H, Origuchi T, Masuyama R, Kosai K, Yanagihara K, Kawakami A.

Front Immunol. 2018 Jan 8;8:1958. doi: 10.3389/fimmu.2017.01958. eCollection 2017.

35.

Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with Rituximab.

Fujita Y, Fukui S, Endo Y, Tsuji S, Takatani A, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki R, Uematsu M, Ishida K, Abe K, Kawakami A.

Intern Med. 2018 Jun 15;57(12):1783-1788. doi: 10.2169/internalmedicine.0215-17. Epub 2018 Jan 11.

36.

MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase γ pathway.

Koga T, Migita K, Sato T, Sato S, Umeda M, Nonaka F, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura KI, Eguchi K, Kawakami A.

Rheumatology (Oxford). 2018 Apr 1;57(4):718-726. doi: 10.1093/rheumatology/kex451.

PMID:
29294109
37.

The influence of aging on the effectiveness of heat stress in preventing disuse muscle atrophy.

Kataoka H, Nakano J, Kondo Y, Honda Y, Sakamoto J, Origuchi T, Okita M.

Physiol Int. 2017 Dec 1;104(4):316-328. doi: 10.1556/2060.104.2017.4.1.

PMID:
29278025
38.

Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus.

Ichinose K, Ohyama K, Furukawa K, Higuchi O, Mukaino A, Satoh K, Nakane S, Shimizu T, Umeda M, Fukui S, Nishino A, Nakajima H, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yoshida M, Kuroda N, Kawakami A.

Clin Immunol. 2018 Aug;193:123-130. doi: 10.1016/j.clim.2017.11.006. Epub 2017 Nov 21.

PMID:
29162406
39.

Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary Nodules.

Watanabe C, Fukui S, Iwamoto N, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Ichinose K, Hirai Y, Tamai M, Nakamura H, Origuchi T, Tabata K, Kawakami A.

Intern Med. 2018 Feb 1;57(3):417-421. doi: 10.2169/internalmedicine.9188-17. Epub 2017 Nov 1.

40.

CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosus.

Umeda M, Koga T, Ichinose K, Igawa T, Sato T, Takatani A, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Yamamoto K, Abiru N, Origuchi T, Ueki Y, Kawakami A.

Clin Immunol. 2018 Feb;187:50-57. doi: 10.1016/j.clim.2017.10.004. Epub 2017 Oct 13.

PMID:
29031579
41.

Comparison of serum inflammatory cytokine concentrations in familial Mediterranean fever and rheumatoid arthritis patients.

Koga T, Kawashiri SY, Migita K, Sato S, Umeda M, Fukui S, Nishino A, Nonaka F, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Eguchi K, Kawakami A.

Scand J Rheumatol. 2018 Jul;47(4):331-333. doi: 10.1080/03009742.2017.1363281. Epub 2017 Sep 2. No abstract available.

PMID:
28868950
42.

Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled.

Kawashiri SY, Fujikawa K, Nishino A, Okada A, Aramaki T, Shimizu T, Umeda M, Fukui S, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Mizokami A, Nakamura H, Origuchi T, Ueki Y, Aoyagi K, Maeda T, Kawakami A.

Arthritis Res Ther. 2017 May 25;19(1):108. doi: 10.1186/s13075-017-1320-2.

43.

Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.

Koga T, Okada A, Fukuda T, Hidaka T, Ishii T, Ueki Y, Kodera T, Nakashima M, Takahashi Y, Honda S, Horai Y, Watanabe R, Okuno H, Aramaki T, Izumiyama T, Takai O, Miyashita T, Sato S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Aoyagi K, Eguchi K, Kawakami A; Japanese RA Patients with RRP Study Group.

PLoS One. 2017 May 15;12(5):e0175281. doi: 10.1371/journal.pone.0175281. eCollection 2017.

44.

Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.

Iwamoto N, Tsuji S, Takatani A, Shimizu T, Fukui S, Umeda M, Nishino A, Horai Y, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Hirai Y, Tamai M, Nakamura H, Terada K, Origuchi T, Eguchi K, Ueki Y, Kawakami A.

PLoS One. 2017 May 4;12(5):e0177057. doi: 10.1371/journal.pone.0177057. eCollection 2017.

45.

Baseline MRI bone erosion predicts the subsequent radiographic progression in early rheumatoid arthritis patients who achieved sustained good clinical response.

Tamai M, Arima K, Nakashima Y, Kita J, Umeda M, Fukui S, Nishino A, Suzuki T, Horai Y, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Yamasaki S, Nakamura H, Origuchi T, Aoyagi K, Uetani M, Eguchi K, Kawakami A.

Mod Rheumatol. 2017 Nov;27(6):961-966. doi: 10.1080/14397595.2017.1294280. Epub 2017 Mar 8.

PMID:
28269999
46.

Development and progression of immobilization-induced skin fibrosis through overexpression of transforming growth factor-ß1 and hypoxic conditions in a rat knee joint contracture model.

Goto K, Sakamoto J, Nakano J, Kataoka H, Honda Y, Sasabe R, Origuchi T, Okita M.

Connect Tissue Res. 2017 Nov;58(6):586-596. doi: 10.1080/03008207.2017.1284823. Epub 2017 Jan 25.

PMID:
28121187
47.

Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years.

Fukui S, Iwamoto N, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Ichinose K, Hirai Y, Tamai M, Nakamura H, Aramaki T, Iwanaga N, Izumi Y, Origuchi T, Migita K, Ueki Y, Sato S, Kawakami A.

Arthritis Res Ther. 2016 Dec 13;18(1):293.

48.

Effects of joint immobilization on changes in myofibroblasts and collagen in the rat knee contracture model.

Sasabe R, Sakamoto J, Goto K, Honda Y, Kataoka H, Nakano J, Origuchi T, Endo D, Koji T, Okita M.

J Orthop Res. 2017 Sep;35(9):1998-2006. doi: 10.1002/jor.23498. Epub 2017 Mar 29.

49.

A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.

Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H, Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M, Ogishima H, Suzuki Y, Kawanami T, Kawanami Iwao H, Sakai T, Fujita Y, Fukushima T, Saito M, Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S, Sumida T.

Mod Rheumatol. 2017 Sep;27(5):849-854. doi: 10.1080/14397595.2016.1259602. Epub 2016 Dec 15.

PMID:
27846767
50.

Synovitis of sternoclavicular and peripheral joints can be detected by ultrasound in patients with SAPHO syndrome.

Umeda M, Kawashiri SY, Nishino A, Koga T, Ichinose K, Michitsuji T, Shimizu T, Fukui S, Nakashima Y, Hirai Y, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Origuchi T, Ueki Y, Kawakami A.

Mod Rheumatol. 2017 Sep;27(5):881-885. doi: 10.1080/14397595.2016.1259971. Epub 2016 Dec 9.

PMID:
27846749

Supplemental Content

Loading ...
Support Center